News
Your contact
Gabriele Klingner
Communications & Marketing Lead
Christiane Proll
PR & Social Media Manager
News and articles from BioM about and for the Bavarian biotechnology industry.
-
2NA FISH from Munich secures additional pre-seed funding for RNA diagnostics platform13.01.20262NA FISH from Munich secures additional pre-seed funding for RNA diagnostics platformThe Munich-based biotech company 2NA FISH GmbH, developer of an innovative platform for spatial RNA biomarker detection in oncology diagnostics, has secured additional pre-seed funding. The… -
LMU President Prof. Tschöp receives prestigious Rolf Luft Award12.01.2026LMU President Prof. Tschöp receives prestigious Rolf Luft AwardProf. Matthias H. Tschöp, President of Ludwig Maximilians-Universität München (LMU), receives the internationally renowned Rolf Luft Award 2026 in recognition of his pioneering research in… -
Ovo Labs announces world’s first rejuvenation of human eggs – hope for millions of aspiring parents09.01.2026Ovo Labs announces world’s first rejuvenation of human eggs – hope for millions of aspiring parentsOvo Labs, a pioneering biotechnology company from Oberschleißheim/Munich, has presented first-time efficacy data for its lead therapeutic EmbryoProtect 1 (EP1) at the UK’s largest fertility… -
Bio<sup>M</sup> to Co-Host the 4th Session of Creative Destruction Lab (CDL) in Munich18.12.2025BioM to Co-Host the 4th Session of Creative Destruction Lab (CDL) in MunichBioM, together with its partner DEEP, the Institute for Deep Tech Innovation at ESMT Berlin, will co-host in Munich the 4th yearly session of Creative Destruction Lab (CDL), an… -
Participation in International Conferences 2026: Explore Attractive Opportunities!18.12.2025Participation in International Conferences 2026: Explore Attractive Opportunities!In 2026, BioM will once again support participation in leading international trade fairs - an excellent opportunity for Bavarian biotechnology companies to showcase themselves at the most… -
T-CURX raises 20 millions US-dollars series A to advance non-viral CAR-T cancer therapies16.12.2025T-CURX raises 20 millions US-dollars series A to advance non-viral CAR-T cancer therapiesT-CURX announced a 20 Mio USD Series A first closing led by BiomedVC to fund pipeline of clinical-stage CAR-T programs and advance proprietary non-viral in vivo CAR-T platform. T-CURX GmbH,… -
CSL ResearchAcceleration Initiative - Applications for start-ups close 24th February 202616.12.2025CSL ResearchAcceleration Initiative - Applications for start-ups close 24th February 2026CSL is a leading global biotech company delivering innovative therapies to help people with life-threatening conditions live full lives. The CSL Research Acceleration Initiative supports… -
m<sup>4</sup> Awardee RevoBITs receives EXIST research transfer funding – EUR 1.25 million for the development of the first smart bioprinter11.12.2025m4 Awardee RevoBITs receives EXIST research transfer funding – EUR 1.25 million for the development of the first smart bioprinterm4 Award winner RevoBITs impresses in the nationwide selection process of EXIST Research Transfer and receives EUR 1.25 million in funding. With its smart bioprinter, the start-up aims to… -
Save the Date: BayOConnect 2026 - The Forum for Biotechnology & Life Sciences10.12.2025Save the Date: BayOConnect 2026 - The Forum for Biotechnology & Life SciencesMark your calendar: On 30 June and 1 July 2026, the biotechnology and life science community will once again gather in Munich for BayOConnect 2026. Experience two days of innovation, dialogue… -
AI4Biotech: Meet the Experts – “Hey Chat, what’s next in Biotech and Medicine?”10.12.2025AI4Biotech: Meet the Experts – “Hey Chat, what’s next in Biotech and Medicine?”*** Agenda now online *** Following up on its successful kickoff in November 2025, the AI4Biotech: Meet the Experts series is going to continue! The “Meet the Experts” event brings together…